Polyserositis due to multisystem inflammatory syndrome in pediatrics: case report
Keywords:
ABDOMINAL PAIN, MULTISYSTEM SYNDROME, PEDIATRICS.Abstract
Introduction: Polyserositis, the result of simultaneous inflammation of several serous membranes, is associated with various diseases, including multisystem inflammatory syndrome in pediatrics. This rare but serious syndrome can develop after a SARS-CoV-2 infection, even in mild or asymptomatic forms of COVID-19.
Objective: provide a complete and educational description of this clinical case, emphasizing the clinical relevance and comprehensive approach in the management of this complex condition.
Case presentation: a case of suspected multisystem inflammatory syndrome in an 8-year-old boy with no previous personal pathological history is presented. The described clinical picture of insidious abdominal pain of several days of evolution and fever, together with the physical examination performed due to suspicion of signs of inflammation with altered values of laboratory tests, leads to indicating an exploratory laparoscopy, where serous inflammatory fluid was found in the abdominal cavity and signs of appendiceal inflammation (classified as phase II appendicitis). In addition, signs of dehydration and neurological compromise were observed. The literature review supports the suspicion of polyserositis associated with multisystem inflammatory syndrome.
Conclusions: the clinical method and complementary examinations in the present case contributed to confirming the diagnosis of polyserositis associated with multisystem inflammatory syndrome that could be related to COVID-19.
Downloads
References
1. Losada I, González J, Roda N, Ventayol L, Borjas Y, et al. Polyserositis: a diagnostic challenge. Rev. Intern Med J [Internet]. 2018 [Citado 13/09/2023]; 48(8): 982–7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29761620/
2. Son M, Friedman K. COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis [Internet]. Uptodate; 2022 [Citado 15/09/2023]. Disponible en: https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis
3. Grech P, Mangion J, Vella S. Post-Streptococcus mitis infection polyserositis. Rev. BMJ Case Rep [Internet]. 2021 [Citado 15/09/2023]; (14): 236704. Disponible en: https://www.bmj.com/company/products-services/rights-and-licensing/permissions/
4. Nakra N, Blumberg D, Herrera A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management. Rev. MDPI - Child [Internet]. 2020 [Citado 16/09/2023]; 7(7): 69. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32630212/
5. Hernández J, Piñeiro D, Martínez J, Correa J, de Armas M, etal.Polyserositis as a Post-Covid-19 Complication. Rev. MEDICC [Internet]. 2022[Consultado10/10/2023]; 24(3-4):57-60.Disponible en: https://pubmed.ncbi.nlm.nih.gov/36417336/
6. Fung M, Vargas A, León S. Síndrome inflamatorio multisistémico pediátrico. Rev. Méd. Sinerg [Internet]. 2021 [Citado 15/10/2023]; 6(5): e664-e664. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/664
7. Whittaker E, Bamford A, Kenny J, Jones C, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Rev. JAMA [Internet]. 2020 [Citado 20/10/2023]; (324): 259-269. Disponible en:https://pubmed.ncbi.nlm.nih.gov/32511692/
8. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: Prospective observational study. Rev. BMJ [Internet]. 2020 [Citado 20/10/2023]; (369): m2094. Disponible en:https://pubmed.ncbi.nlm.nih.gov/32493739/
9. Organización Mundial de la Salud. Multisystem inflammatory syndrome in children and adolescents with COVID-19 [Internet]. Geneva: WHO; 2020 [Citado 25/10/2023]. Disponible en: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children- andadolescents- with-covid-19
10. Godfred S, Bryant B, Leung J, Oster M, Conklin L. COVID-19–Associated Multisystem Inflammatory Syndrome in Children-United States, March–July 2020. Rev. MMWR [Internet]. 2020 [Citado 25/10/2023]; 69(32): 1074-180. Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6932e2-H.pdf
11. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. Rev. JAMA Pediatr [Internet]. 2020 [Citado 29/10/2023]; (1467). Disponible en: https://dx.doi.org/doi:10.1001/jamapediatrics.2020
12. Noda A, Castro B, López, Robaina G. Síndrome inflamatorio multisistémico en niños asociado a COVID-19. Rev Cub Pediatr [Internet]. 2020 [Citado 05/11/2023]; 92(Suppl1): e1202. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312020000500010&lng=es
13. Heidarpour M, Haghighatpanah M, Rezvanian H, Yadegarfar M, Mozafari A, Vakhshoori M, et al. Case Report Polyserositis: An Extremely Rare Life-Threatening Manifestation of Pheochromocytoma. Rev. Hindawi [Internet]. 2020 [Citado 20/11/2023]; 2020 (ID 8814699): 1-3. Disponible en: https://doi.org/10.1155/2020/8814699
14. DeBiasi R, Song X, Delaney M, Bell M, Smith K. Severe COVID-19 in children and young adults in the Washington, D. C.: Metropolitan Region. Rev. J Pediatr [Internet]. 2020 [Citado 30/11/2023]; (20): 30581-3. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217783/
15. Cañón J, Cobos A, Mateus J, Becerra E, Gómez J, Mora V. Vista de Abdomen agudo quirúrgico relacionado con síndrome inflamatorio multisistémico asociado a covid-19 en pediatría: reporte de caso. Rev. MÉDUIS [Internet]. 2022 [Citado 15/12/2023]; 35(2): 97-105. Disponible en: https://revistas.uis.edu.co/index.php/revistamedic
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/